Author

R. E. Mitrut

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

J. N. Leonard· 3 shared D. M. Stranford· 2 shared B. N. DiBiase· 1 shared B. Zhang· 1 shared C. S. Harper· 1 shared I. J. Hammitt-Kess· 1 shared J. Ahn· 1 shared J. M. Chan· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

J. N. Leonard

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

HaloTag display enables quantitative single-particle characterization and functionalization of engineered extracellular vesicles

R. E. Mitrut, D. M. Stranford, B. N. DiBiase, J. M. Chan, M. D. Bailey, M. Luo, C. S. Harper, T. J. Meade, M. Wang, J. N. Leonard

The paper develops a HaloTag-based system for quantitatively characterizing engineered proteins on extracellular vesicles and compares it to antibody labeling.

bioRxiv · Sep 25, 2023 · PreprintBioengineering

Comparative evaluation of synthetic cytokines for enhancing production and performance of NK92 cell-based therapies

S. Deol, P. S. Donahue, R. E. Mitrut, I. J. Hammitt-Kess, J. Ahn, B. Zhang, J. N. Leonard

The paper evaluates synthetic cytokines to enhance NK92 cell production and performance, finding that membrane-bound cytokines improve cytotoxicity and expansion.

bioRxiv · May 13, 2023Bioengineering

Elucidating design principles for engineering cell-derived vesicles to inhibit SARS-CoV-2 infection

T. F. Gunnels, D. M. Stranford, R. E. Mitrut, N. Kamat, J. N. Leonard

This study evaluates cell-derived vesicles as decoy nanoparticles to inhibit SARS-CoV-2 infection, finding they are effective against multiple variants and manufacturing methods.

bioRxiv · Dec 4, 2021Bioengineering